(Q50440257)
Statements
A Phase 1, Open-Label Study of the Biodistribution, Pharmacokinetics, and Dosimetry of 223Ra-Dichloride in Patients with Hormone-Refractory Prostate Cancer and Skeletal Metastases. (English)
1 reference
Sarah J Chittenden
Cecilia Hindorf
Christopher C Parker
Brenda E Pratt
16 July 2015
1 reference